Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.jvca.2015.10.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Thrombus vs Tumor: Use of AngioVac in a RV Mass.
JACC Case Rep
October 2024
Division of Cardiovascular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
This paper present a challenging case of a right ventricular mass in a patient who was at high surgical risk for open removal. The minimally invasive AngioVac device has been used with a successful 50% reduction in mass burden. This report illustrates AngioVac as a safe alternative to invasive surgery.
View Article and Find Full Text PDFArticle Synopsis
- Intravascular and intracardiac masses include thrombi, tumors, and vegetations, impacting the heart's chambers and circulation.
- Treatment has traditionally been surgical or involves anticoagulation, but there's a shift towards minimally invasive techniques due to patient complexities.
- The AngioVac System, initially for right-sided heart thrombi, has expanded its use to treat right-sided endocarditis and left-sided masses effectively.
Pulmonary valve infective endocarditis (PVIE) fully removed by the percutaneous approach with Angiovac: First report on 6-month follow-up.
Kardiol Pol
October 2024
Departament of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznań, Poland.
A Retrospective Analysis of AngioVac Outcomes at a Tertiary Care Center.
J Soc Cardiovasc Angiogr Interv
June 2024
Division of Cardiology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia.
Background: The AngioVac system is a vacuum aspiration device approved for removal of right-sided cardiac thrombi. It has also been used for management of right-sided endocarditis in selected cases. Retrospective case series have reported high success rate and acceptable 30-day mortality, but there is limited data regarding outcomes beyond the immediate postoperative period.
View Article and Find Full Text PDFMyxoma Involving the Pulmonary Valve - A Case Report of an Atypical Cardiac Tumor, Treated Using an Unusual Approach.
Eur J Case Rep Intern Med
May 2024
Allegheny General Hospital, Pittsburgh, USA.
Background: Atypical myxoma has been reported in various locations in the heart, however, myxoma involving the pulmonary valve is rare. Here we present a case of pulmonic valve myxoma which was resected via a percutaneous approach.
Case Report: A 66-year-old female with known metastatic adenocarcinoma of the lung, and chronic obstructive pulmonary disease presented with acute onset shortness of breath for two days.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!